Qualified Person: The scientific and technical data contained in this news release was approved by Cornell McDowell, P.Geo., a non-independent “qualified person” under the National Instrument 43-101 ...

Preventative treatment can help reduce the frequency of migraine attacks, helping children and adolescents to better manage the condition day-to-day. AJOVY is administered once a month and available ...

NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) (“BAM”), a leading global alternative asset manager headquartered in New York with over $1 trillion ...

Built on Digital Science's Dimensions  – the world’s largest interconnected global research database – Dimensions Author Check offers unmatched transparency into authors’, editors’ and reviewers’ ...

Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced the release of Descartes Visual Compliance™ AI Assist, the latest ...

Buchanan is an active investor who currently serves on the Boards of Directors for several medical technology companies, including Element Science, Aerin Medical, Route 92 Medical, Procyrion, and ...

Bitget , the leading cryptocurrency exchange and Web3 company, has announced the feature of Towns Protocol (TOWNS) on its Launchpool as well as listing it for spot trading. Trading for the TOWNS/USDT ...

Further efforts were made to improve Ascom’s operational efficiency through a cost improvement plan implemented during the second half of 2024 and the first half of 2025. Ascom established a new and ...

Now available as an add-on to Facephi’s Behavioral Biometrics suite, Advanced Injection Defense can be integrated into both new customer onboarding and ongoing authentication processes. It meets ...

GXO Logistics, Inc. (NYSE: GXO) today announced results for the second quarter 2025. Malcolm Wilson, chief executive officer of GXO, said, “In the second quarter, we generated revenue of $3.3 billion, ...

Total revenue for the three months ended June 30, 2025 increased by $1.5 million as compared to the three months ended June 30, 2024, primarily as a result of increases in Incyte revenue of $1.5 ...

ZUG, Switzerland, August 5, 2025 – MoonLake Immunotherapeutics (NASDAQ:MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating next-level therapies for ...